Sex differences in hospital readmission among colorectal cancer patients

Journal of Epidemiology and Community Health

Volumn 59, Issue 6, 2005, Pages 506-511

  González, Juan Ramon ^a   Fernandez, Esteve ^a,b   Moreno, Víctor ^a   Ribes, Josepa ^a   Peris, Mercè ^a   Navarro, Matilde ^a   Cambray, Maria ^a   Borràs, Josep Maria ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; GENDER DISPARITY; HEALTH CARE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; COVARIANCE; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; SEX DIFFERENCE; SEX RATIO; SOCIOECONOMICS; SPAIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADULT; AGED; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; EDUCATIONAL STATUS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT READMISSION; PROGNOSIS; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 20344384768     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2004.028902     Document Type: Article

References (39)

1. Fernandez E, Bosetti C, La Vecchia C, et al. Sex differences in colorectal cancer mortality in Europe, 1955-1996. Eur J Cancer Prev 2000;9:99-104.
2. La Vecchia C, Negri E, Levi F, et al. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998;34:118-41.
3. Verbrugge LM. Sex differentials in health. Public Health Rep 1982;97:417-37.
4. Ross CE, Bird CE. Sex stratification and health lifestyle: consequences for men's and women's perceived health. J Health Soc Behav 1994;35:161-78.
5. Macron S, Clarke L, Joshi H. Women's health: dimensions and differentials. Soc Sci Med 1996;42:1203-16.
6. Sayer GP, Britt H. Sex differences in morbidity: a case of discrimination in general practice. Soc Sci Med 1996;42:257-64.
7. Borrell C, Pasarin MI. The study of social inequalities in health in Spain: where are we? J Epidemiol Community Health 1999;53:388-9.
8. Borrell C, Fernandez E, Schiaffino A, et al. Social class inequalities in the use of and access to health services in Catalonia, Spain: what is the influence of supplemental private health insurance? Int J Qual Health Care 2001;13:117-25.
9. Regidor E, de Mateo S, Gutiérrez-Fisac JL, et al. Diferencias socioeconómicas en la utilización y accesibilidad de los servicios sanitarios en España. Med Clin (Barc) 1996;107:285-8.
10. Artazcoz L, Moya C, Vanaclocha H, et al. La salud de las personas adultas. Gac Sanit 2004;18(suppl 1):56-88.
11. Borras JM, Guillen M, Sanchez V, et al. Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev 1999;8:427-34.
12. Faggiano F, Partanen T, Kogevinas M, et al. Socioeconomic differences in cancer incidence and mortality. In: Kogevinas M, Pearce N, Susser M, et al, eds. Social inequalities and cancer. Lyon: IARC Scientific Publications, 1997:65-206.
13. McMahon LF Jr, Wolfe RA, Huang S, et al. Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care 1999;37:712-17.
14. Govindarajan R, Shah RV, Erkman LG, et al. Racial differences in the outcome of patients with colorectal carcinoma. Cancer 2003;97:493-8.
15. Wrigley H, Roderick P, George S, et al. Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health 2003;57:301-9.
16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
17. Librero J, Peiró S, Ordiñana R. Chronic comorbidity and outcome of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol 1999;52:171-9.
18. Wang MC, Chang SH. Nonparametric estimation of a recurrent survival function. J Am Stat Assoc 1999;94:146-53.
19. Peña EA, Strawderman RL, Hollander M. Nonparametric estimation with recurrent event data. J Am Stat Assoc 2001;96:1299-315.
20. Kelly PJ, Lim LL. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med 2000;19:13-33.
21. Oakes, DA. Frailty models for multiple event times. In: Kein JP, Goel PK, eds. Survival analysis: state of the art. Dordrecht: Kluwer Academic, 1992:371-9.
22. Pickles A, Crouchley R. A comparison of frailty models for multivariate survival data. Stat Med 1995;14:1447-61.
23. The Comprehensive R Archive Network. http://cran.r-project.arg (accessed 8 Jan 2004).
24. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 2001;93:501-15.
25. Macintyre S, Hunt K, Sweeting H. Gender differences in health: are things really as simple as they seem? Soc Sci Med 1996;42:617-24.
26. Hibbard JH, Pope CR. Gender roles, illness orientation and use of medical services. Soc Sci Med 1983;17:129-37.
27. Ruiz-Cantero MT, Verdú-Delgado M. Sesgo de género en el esfuerzo terapéutico. Gac Sanit 2004;18(suppl 1):118-25.
28. Fernández E, Schiaffino A, Rajmil L, et al. Gender inequalities in health and health care services use in Catalonia (Spain). J Epidemiol Community Health 1999;53:218-22.
29. Goodman DC, Fisher E, Stukel TA, et al. The distance to community medical care and the likelihood of hospitalization: is closer always better? Am J Public Health 1997;87:1144-50.
30. Lamont EB, Hayreh D, Pickett KE, et al. Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst 2003;95:1370-5.
31. Cleary PD, Greenfield S, Mulley AG, et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA 1991;226:73-9.
32. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM adminstrative databases. J Clin Epidemiol 1992;45:613-19.
33. Melfi C, Holleman E, Arthur D, et al. Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data. J Clin Epidemiol 1995;48:917-26.
34. Brailer DJ, Droch E, Pauly MV, et al. Comorbidity-adjusted complications risk. A new outcome quality measure. Med Care 1996;34:490-505.
35. Siegler EL, Stineman MG, Maislin G. Development of complications during rehabilitation. Arch Intern Med 1994;154:2185-90.
36. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003;21:1293-300.
37. Scharg D, Gelfand SE, Bach PB, et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology and end results-Medicare. J Clin Oncol 2001;19:3712-18.
38. Hart JT. The inverse care law. Lancet 1971;i:405-12.
39. van Doorslaer E, Wagstaff A, van der Burg H, et al. Equity in the delivery of health care in Europe and the US. J Health Econ 2000;19:553-83.